COMMITMENTS (Narrative) (Details) - License Agreement [Member] - Technology-based intangible assets	12 Months Ended
	Sep. 30, 2022 CAD ($)
Other Commitments [Line Items]
Minimum advance royalty payments	$ 85,000
Milestone payment to be paid upon filing an Investigational New Drug (IND) Application.	20,000
Milestone payment to be made at the start of a Phase II clinical trial	50,000
Milestone payment to be made at the start of a Phase III clinical trial	900,000
Milestone payment to be made at application for marketing approval, and with further milestone payments on the second and additional compounds	1,450,000
Amount of milestone payment made for filing an Investigational New Drug (IND) Application.	$ 20,000